Vascular Protective Effects on Changes of AspiRin in Patients with New Ischemic Stroke While TAking ASpirin (VERITAS)
Not Applicable
Recruiting
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0003931
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1172
Inclusion Criteria
Patients with ischemic stroke admitted within 48 hours of stroke onset, those with non-cardioembolic ischemic stroke, and those with prior use of aspirin before a new ischemic stroke.
Exclusion Criteria
Patients who used anticoagulants during admission or at discharge and those who did not use antiplatelet therapy during admission or at discharge.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method vascuar events: stroke, myocardial infarction, vascular death
- Secondary Outcome Measures
Name Time Method composite events: stroke, myocardial infarction, all death;stroke